Connection
Matthew Ellis to Insulin-Like Growth Factor Binding Protein 3
This is a "connection" page, showing publications Matthew Ellis has written about Insulin-Like Growth Factor Binding Protein 3.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.024 |
|
|
|
-
Ma CX, Suman VJ, Goetz M, Haluska P, Moynihan T, Nanda R, Olopade O, Pluard T, Guo Z, Chen HX, Erlichman C, Ellis MJ, Fleming GF. A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer. Breast Cancer Res Treat. 2013 May; 139(1):145-53.
Score: 0.024